KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $127,000 | -48.6% | 37,280 | -43.3% | 0.10% | -54.1% |
| Q2 2018 | $247,000 | -11.2% | 65,800 | -3.1% | 0.23% | -11.2% |
| Q1 2018 | $278,000 | -10.6% | 67,910 | +1.5% | 0.26% | -2.6% |
| Q4 2017 | $311,000 | +20.1% | 66,910 | +83.3% | 0.26% | +14.7% |
| Q3 2017 | $259,000 | -1.9% | 36,500 | 0.0% | 0.23% | -0.9% |
| Q2 2017 | $264,000 | +41.2% | 36,500 | +20.5% | 0.23% | +39.5% |
| Q1 2017 | $187,000 | +18.4% | 30,300 | +13.1% | 0.17% | +9.9% |
| Q4 2016 | $158,000 | – | 26,800 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |